| Advice You |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Marketing > Common Mistakes in Trade Show Exhibiting |
|
Advice You - Common Mistakes in Trade Show Exhibiting
Failure to implement a consistent marketing plan.
Your exhibiting efforts must be part According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product of an overall marketing scheme that is consistent and engaging. Many exhibitors start from scrat ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in ch when designing their trade show display, and their booth ends up looking entirely different f lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. rom the rest of their marketing material. While it is important to have a fresh look at every tr here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe ade show, it is also important to implement a consistent marketing plan to build brand recogniti d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro on. Failure to set goals for your trade show experience. It is important to set measur ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc able goals months in advance of your trade show. How can you possibly determine whether or not y easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi our exhibiting experience was a success if you never established what you were trying to achieve nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically ? Suppose you want to generate 50 quality leads from your trade show. If you make it an establis and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ hed goal, this will be easy to measure. Failure to give attendees and other exhibitors a rea ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi son to visit your booth.
Do not assume that visitors will simply wander into your display ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a area without incentive. There are a number of methods exhibitors use to draw attention to their dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod booths, many of which are put in place before the show even begins. Using pre-show mailers that cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin highlight specific points of interest is a great way to make sure your booth is full of activity tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen . Use any avenue available to you to generate interest in your booth. Failure to follow up w t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel ith the leads you generate.
The biggest and most common mistake exhibitors make is that th ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust ey fail to have a plan in place to turn leads into sales. Your pre-show mailers, exhibit display y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products s, and booth staff is absolutely useless if all the leads they generate go to waste. You would b . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de e amazed to learn how many veteran exhibitors fail to implement a plan to follow up on the leads elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip they generate. Unless you have a plan in place, you may as well not even attend the trade show. tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:10 Little Known Business Growth Secrets Uncovered Leadership Lessons from the Great Pyramids Managing Cultural Diversity - A Key to Organizational Success
|